Vivo Bio Tech
Hyderabad-based preclinical CRO offering GLP toxicology, pharmacology and pharmacokinetic studies across rodent and non-rodent species.
107 contract research organizations in our directory work with Rat, across 18 countries. 70 report GLP capability and 22 report AAALAC accreditation. Compare their species, services and accreditations below, and contact labs directly from their profiles.
The rat is the standard rodent species for regulatory toxicology and the usual first species for PK. Sprague Dawley and Wistar Han rats carry decades of historical control data, and their size allows serial blood sampling, cannulation, telemetry and surgical procedures that are difficult in mice.
Rats are also widely used in CNS research. Their larger brain suits stereotaxic surgery, ICV cannulation, microdialysis and electrophysiology, and intrathecal catheterization and CSF sampling are well established. Behavioral neuroscience, pain models and abuse liability studies often use rats for the same reasons.
For toxicology, check which strain and supplier the lab uses, because historical control data are only useful when they match your study animals.
Showing 107 CROs. Order rotates daily so no lab is permanently listed first.
Hyderabad-based preclinical CRO offering GLP toxicology, pharmacology and pharmacokinetic studies across rodent and non-rodent species.
Indian GLP test facility offering regulatory toxicology studies for chemicals, agrochemicals and pharmaceuticals.
St. Louis area CRO providing toxicology, pharmacokinetic and bioanalytical services, including inhalation work.
Preclinical GLP toxicology and safety pharmacology across small and large species.
German DMPK CRO offering in vitro ADME, in vivo pharmacokinetics and bioanalysis for discovery and early development.
Animal model company offering custom genetically engineered rodents together with in vivo pharmacology and AAV services, with operations in the US and China.
Lyon-based company creating genetically engineered and humanized rodent models, with catalog models and in vivo research services.
Integrated drug discovery CRO in Nottingham with in vivo pharmacology, DMPK and bioanalysis alongside chemistry and biology.
Bengaluru preclinical CRO providing pharmacology, pharmacokinetic and toxicology studies.
French CRO specializing in in vivo infection models for antibacterial and antifungal drug development.
Korean nonclinical pharmacology CRO in the Biotoxtech group offering efficacy studies, PCR-based biodistribution for cell and gene therapies, and GLP bioanalysis.
Global R&D services including discovery, DMPK, toxicology, bioanalysis, and manufacturing support.
Contract vivarium operator providing turnkey animal housing, husbandry, veterinary and technical research services for biotech teams, with in vivo study support.
Korean CRO covering GLP toxicity, PK and efficacy studies through to clinical trials for drugs, devices and other products.
Israeli preclinical CRO offering in vivo pharmacology and disease model studies.
Hyderabad discovery services company offering biology and DMPK support alongside chemistry.
Specialty CRO focused on preclinical kidney disease models and renal pathology for nephrology drug programs.
French neuroscience CRO dedicated to in vitro and in vivo models of neurodegenerative and neurological disease, with a US office.
Texas preclinical CRO offering xenograft and other oncology models, efficacy, pharmacology and toxicology studies.
Integrated CRO-CDMO in India whose discovery biology group provides in vivo pharmacology, DMPK and bioanalysis for small molecule programs.
Kentucky CRO developing immunodeficient rat and mouse models, offering xenograft efficacy and safety studies in larger rodent hosts.
Integrated discovery and development services company in India offering in vivo pharmacology, DMPK, bioanalysis and safety assessment alongside chemistry and biologics services.
Bengaluru-based preclinical CRO, part of Eurofins, offering GLP safety assessment, DMPK and discovery services for pharmaceutical and agrochemical sponsors.
Hungarian non-clinical CRO founded in 1982 offering GLP general, genetic and reproductive toxicology for pharmaceutical, chemical and agrochemical sponsors.
Maryland CRO specializing in infectious disease and vaccine research, offering in vitro and in vivo efficacy models and immunological assays.
Integrated CRO/CDMO spanning preclinical to early clinical, including safety assessment and bioanalysis.
Shanghai provider of genetically engineered rodent models with phenotyping and in vivo pharmacology services.
Long-established Japanese CRO with large GLP nonclinical safety facilities and deep nonhuman primate experience, supporting toxicology, safety pharmacology and pharmacokinetics.
Michigan CRO offering in vivo ADME and pharmacokinetics, LC-MS/MS bioanalysis and biochemistry, with a niche in ocular drug development.
Not-for-profit research institute in Birmingham, Alabama providing contract drug discovery and preclinical development, including infectious disease and BSL-3 work, oncology models, ADME, bioanalysis, toxicology and…
North Carolina CRO specializing in immunotoxicology, including GLP immune function assays for drugs, chemicals and biologics.
Korean non-clinical CRO offering IND and NDA-enabling GLP toxicology, including general, reproductive and genetic toxicity, carcinogenicity and safety pharmacology, with NHP capacity through its group companies.
Munich-area contract laboratory providing GLP toxicology, genetic toxicology, biocompatibility and microbiology testing for pharmaceutical, chemical and medical device sponsors.
Independent nonprofit contract research organization with capabilities including inhalation toxicology and high-containment infectious disease research.
French neuroscience CRO offering in vitro and in vivo models for neurological and neurodegenerative drug discovery.
Preclinical CRO offering in vivo pharmacology, toxicology, and surgical services.
Vector design and manufacturing company that also offers AAV biodistribution profiling services, including barcoded multiplex studies in rodents and NHPs.
French preclinical CRO offering in vivo pharmacology in neuroscience, pain and dermatology, plus related safety studies.
Indian integrated drug discovery CRO offering in vivo pharmacology and DMPK alongside chemistry and biology.
With over 15 years of hands-on preclinical surgical experience, I deliver expert-level surgical support for in vivo studies across a broad range of therapeutic areas. I specialize in CNS drug delivery in nonhuman…
Independent German preclinical CRO conducting GLP toxicology, reproductive toxicology, carcinogenicity and safety pharmacology studies across rodent and non-rodent species.
Specialty preclinical CRO focused on hearing research, offering ototoxicity, otoprotection and auditory efficacy studies.
Specialty CRO focused on cardiovascular safety pharmacology and cardiovascular toxicology, including telemetry and hemodynamic studies in non-rodent species.
Bengaluru CRDMO offering discovery services including DMPK, safety and bioanalysis alongside development and manufacturing.
French CRO focused on neurodegeneration and brain aging, offering in vivo models and readouts for Alzheimer's and related diseases.
Ophthalmology-focused preclinical CRO offering retinal and anterior segment disease models, ocular dosing and functional readouts.
Korean nonclinical CRO providing early PK, TK and bioanalytical method development and sample analysis.
Contract toxicology laboratory known for dermal, ocular and acute toxicity testing, including in vitro alternatives, for pharmaceutical, chemical and consumer products.
Nonclinical CRO supporting infectious disease and other in vivo studies; bioanalysis and pathology support.
Indian GLP-certified preclinical CRO providing toxicology and safety studies.
Preclinical in vivo pharmacology and toxicology with aerosol/inhalation expertise.
Independent Danish CRO focused on early in vivo pharmacology in rodents, with particular expertise in mouse cancer and immuno-oncology models.
French CRO combining early clinical development with preclinical pharmacology, offering CNS and cardiovascular safety pharmacology and translational neuroscience models.
German CRO offering integrated discovery, DMPK, bioanalysis and early development services across sites in Germany and France.
Preclinical CRO focused on rodent models of autoimmune and inflammatory disease, such as EAE, arthritis and colitis, with supporting histology, cytokine analysis and flow cytometry.
French preclinical CRO specializing in bone, joint and inflammatory disease models with histology and imaging readouts.
Fraunhofer institute for toxicology and experimental medicine providing GLP inhalation toxicology, respiratory disease models and translational research under contract.
Translational neuroscience CRO with sites in the UK, Ireland and Canada offering CNS disease models, EEG and behavioral pharmacology.
Medical device focused CRO covering biocompatibility, preclinical surgical and interventional research, histopathology and regulatory consulting. Its Minneapolis preclinical site (formerly American Preclinical Services)…
Japanese preclinical CRO offering GLP safety and efficacy studies for drugs, devices and regenerative products, with long minipig experience.
Large CRO with global preclinical safety assessment, DMPK, and bioanalytical services.
Preclinical CRO offering discovery, DMPK, toxicology, surgical models, and specialty pathology.
Preclinical oncology and immuno-oncology CRO with orthotopic and metastatic models, whole-body imaging and GLP toxicology, with sites in Australia and the US.
Swedish CRO specializing in rodent models of arthritis, autoimmunity and inflammation.
German preclinical CRO offering in vivo pharmacology, pharmacokinetic and exploratory safety studies.
Government-funded Korean research institute providing GLP nonclinical safety studies, including inhalation toxicology, safety pharmacology and reproductive toxicity.
In vivo pharmacology CRO near Philadelphia running a broad catalog of efficacy models across CNS, pain, metabolic and inflammatory disease.
Ophthalmology-focused preclinical CRO offering ocular efficacy models, formulation screening, ocular PK and tolerability studies.
Australian bioanalytical and toxicology CRO with OECD GLP labs, supporting nonclinical toxicology and clinical bioanalysis.
Biomere (a JOINN company) is a preclinical CRO based in Worcester, MA. Services include non-GLP PK/PD, discovery toxicology, surgical services, disease models, and laboratory sciences. Surgical services include…
Independent UK preclinical CRO offering GLP general, reproductive and juvenile toxicology studies for pharmaceutical and biotech sponsors.
Preclinical CRO near Toulouse specializing in metabolic disease pharmacology, including obesity, diabetes and NASH/MASH models.
Non-clinical CRO near Milan and part of the NMS Group, offering GLP safety assessment and toxicology, safety pharmacology and preclinical regulatory consulting to move candidates toward IND/CTA.
Preclinical efficacy CRO in the Boston area running predictive animal models across inflammation, mucositis, oncology-supportive care and other indications for biotech and pharma sponsors.
GLP-accredited preclinical CRO headquartered in Denmark with sites in Sweden, Austria and the UK. Known for Gottingen minipig work and regulatory toxicology, with discovery pharmacology including CNS and…
Preclinical CRO with roots in a Chinese Academy of Sciences safety center, offering pharmacology, DMPK and safety evaluation with GLP operations in Shenzhen.
Preclinical in vivo pharmacology with CNS/behavioral expertise and multiple disease models.
Finnish preclinical CRO focused on bone and joint disease, bone metastasis and oncology models, including osteoarthritis and osteoporosis efficacy studies.
Long-established Japanese preclinical CRO providing toxicology, carcinogenicity, genetic toxicity and pharmacology studies.
Preclinical CRO with GLP laboratories near Budapest and offices in Munich, offering safety assessment, ADME-PK, bioanalysis and pharmacodynamic models.
Danish preclinical CRO and peptide discovery company known for metabolic, liver and kidney disease models with AI-supported histology and 3D imaging readouts.
Preclinical CRO in West Michigan specializing in targeted CNS delivery. Long track record supporting intrathecal, intracerebroventricular and cisterna magna dosing, CSF and tissue distribution, pharmacokinetics and…
Preclinical pharmacology CRO in Shanghai with specialty efficacy models in autoimmunity, inflammation, bone and orthopedics, oncology and metabolic disease, plus supporting PK/PD and exploratory toxicology.
Ophthalmology-dedicated CRO near Nice offering ocular efficacy models, GLP ocular safety and PK, bioanalysis and clinical services.
Preclinical CRO in the Research Triangle specializing in ophthalmic disease models, ocular dosing and retinal function readouts.
Preclinical CRO in Northern Ireland, part of QIMA Life Sciences, running non-GLP rodent PK, dose range finding, biodistribution and disease model studies.
Korean non-clinical CRO focused on efficacy testing of new drug candidates, with research facilities in Songdo, Incheon.
Bay Area preclinical CRO offering GLP and non-GLP toxicology, pharmacology and efficacy models with an in-house histopathology lab, including tissue cross-reactivity and histomorphometry.
Vertically integrated nonhuman primate CRO in South Carolina combining on-site breeding with discovery pharmacology, GLP toxicology, vaccine and gene therapy studies.
South Korea's first private non-clinical CRO, providing GLP toxicity, safety pharmacology, pharmacokinetic and efficacy studies for drugs, chemicals and biologics.
Preclinical research company specializing in wound healing, biofilm and infection models for drugs and medical devices, including custom surgical models and electron microscopy.
Polish drug discovery CRO providing integrated chemistry, biology, DMPK and translational research services.
Texas contract laboratory providing GLP toxicology and safety testing for chemical, agrochemical, pharmaceutical and consumer product sponsors.
OECD GLP-certified preclinical CRO near Bengaluru providing regulatory toxicology for pharmaceuticals, biologics, devices and chemicals.
Beijing-based preclinical CRO focused on GLP safety evaluation, with branches across China and support for biologics, nucleic acid and cell and gene therapies.
Global preclinical/clinical CRO with extensive safety assessment, pharmacology, and discovery services.
Italian GLP CRO near Rome providing regulatory toxicology and safety studies for pharmaceuticals, chemicals and agrochemicals.
Indian GLP CRO providing regulatory toxicology and safety studies for pharmaceuticals, agrochemicals, chemicals and biologics.
Shanghai-based nonclinical CRO with GLP safety evaluation, pharmacology, DMPK, bioanalysis and biomarker services for small molecules, biologics and cell and gene therapies, operating several sites in China.
Edmonton CRO providing anti-infective drug discovery support, including in vivo infection models and pharmacokinetics.
Contract testing laboratory providing GLP toxicology, analytical and bioanalytical chemistry for pharmaceutical, chemical, agrochemical, consumer and food ingredient sponsors.
Montreal-based neuroscience CRO combining neurodegenerative disease models with MRI imaging, quantitative neuropathology and image analysis.
Danish preclinical imaging CRO offering PET, SPECT, CT and MRI studies, radiopharmaceutical development support and oncology efficacy models.
Preclinical CNS CRO offering behavioral pharmacology, translational neuroscience, EEG and disease models for psychiatric and neurological programs.
CRO providing DMPK, bioanalysis, toxicology, and related preclinical services.